Back
Axonics 10K Form
Sell
46
AXNX
Axonics
Last Price:
57.30
Seasonality Move:
-5.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AXNX News And Ratings
See the #1 stock for the next 7 days that we like better than AXNX
AXNX Financial Statistics
Sales & Book Value
| Annual Sales: | $273.7M |
|---|---|
| Cash Flow: | $-19.47M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $11.90 |
| Price / Book: | 4.82 |
Profitability
| EPS (TTM): | -0.67000 |
|---|---|
| Net Income (TTM): | $-32.18M |
| Gross Margin: | $197.67M |
| Return on Equity: | -5.88% |
| Return on Assets: | -5.16% |
Axonics Earnings Forecast
Key Axonics Financial Ratios
- The Gross Profit Margin over the past 7 years for AXNX is 72.22%.
- The Selling, General & Administrative Expenses for AXNX have been equal to 71.71% of Gross Profit Margin.
- The Research & Development expenses have been 12.57% of Revenue.
- The Interest Expense is -4.07% of Operating Income.
- The Net Earning history of AXNX is -21.81% of Total Revenues.
- Per Share Earnings over the last 7 years have been positive in 3 years.
Axonics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Medical Devices |
| Sector: | Healthcare |
| Current Symbol: | AXNX |
| CUSIP: | 05465P |
| Website: | axonics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 14.19 |
| Quick Ratio: | 11.81 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 170.29 |